- Investment Expertise
We are committed to supporting the insurance sector and have a dedicated insurance solutions team.
We’re finding that an increasing number of institutional, pension fund and high-net-worth investors are turning to private equity in order to enhance their portfolio performance.
- Our insight
The House View process provides a consistent macroeconomic framework to analysing global financial markets.
Our Head of Global Strategy, Andrew Milligan, introduces the latest edition of Global Outlook, a summary of our House View.
Standard Life Investments’ Global Strategy team provide regular analysis of the key economic data that has been influencing financial markets.
Our global strategists combine valuable experience, thorough research and analysis to tackle major issues of the moment.
Governance and stewardship is about making sure that companies’ operational processes and policies are robust and responsible.
- How we discharge our stewardship responsibilities
- Our policy for managing conflicts of interests
- How we monitor our investee companies
- Our guidelines for escalating engagement
- Our willingness to act collectively with other investors
- Our policy on voting and voting disclosure
- How we report on stewardship to our clients
We recognise the importance of transparency and accountability when it comes to our stewardship responsibilities. To this end, we have published an annual review of our governance and stewardship activities, which provides an account of how we have fulfilled our responsibilities. Please select the link below to view the 2015 annual review.2015 annual review
- Responsible Investment
We recognise that the management of environmental and social responsibilities is subject to many factors, and take into account the particular circumstances, industries and locations in which the companies operate.
We've produced guidelines on responsible investment to explain how we evaluate the environmental and social policies of the companies in which we are (or might be) an investor.
Our experience in operating across many different investment cycles and markets provides us with the context to manage change. Throughout these cycles, we have the people, philosophy and proficiency of process to plot what we believe is the right course for our clients’ assets.
- Secure content
Weekly Economic Briefing
25 April 2017
The European Central Bank (ECB) was late to the quantitative easing (QE) party. It purchased EUR 100bn in government bonds under its Securities Market Programme (SMP) during the Eurozone sovereign debt crisis. The central bank also launched two covered bond purchase programmes, amounting to just EUR 15bn in total. However, large scale and broad-based asset purchases aimed at boosting growth and inflation only started in earnest in 2015 – almost seven years after the Fed’s first foray into QE. Since then, the ECB has bought some EUR 1.8tn in assets (see Chart 5) – around 16% of GDP. It estimates that this, and other measures, will add 1.7 percentage points to real GDP between 2016 and 2019. Better late than never.
December’s decision to reduce monthly purchases from EUR 80bn to EUR 60bn was controversial. One interpretation of this step is that it reflected an improving economic outlook. Deflation risks had receded as commodity price disinflation faded, while the recovery appeared to be more entrenched. Another, less benign, interpretation is that the ECB reacted to the prospect of running up against technical constraints to purchases, particularly in government bond markets. The ECB has committed to buy bonds from member states according to the weights from its capital key, limit purchases to 33% of any individual bond and buy no more than 33% of the total of any member state’s debt (including existing SMP holdings). These constraints place limits on the scale of asset purchases. The recent slowdown in purchases has been interpreted in some quarters as a tacit signal from the central bank that it was approaching these limitations. The ECB denies this, and continues to signal a willingness to accelerate purchases if required. However, the scarcity issue is clearly growing as the QE programme matures.
This may be a moot point if the economy continues to recover. Indeed, if the central bank’s forecasts for growth and inflation are achieved, it will likely taper asset purchases in 2018. However, if the economy disappoints, the ECB faces a dilemma. It is difficult to estimate with precision how close the ECB is running to its issue/issuer limits, but these constraints will probably start to bind in 2018 across a number of member states. In this scenario there are a few options. The best response would be a helping hand from governments. Fiscal stimulus would support growth and inflation, while also increasing the issuance of bonds for the ECB to buy. Alternatively, the ECB could break its own rules. It previously refused to buy bonds below the deposit rate, but removed this restriction in January. It could commit to raising the issue/issuer limit, although this would be controversial internally. Instead, it could shift purchase weightings away the capital key. There is some evidence that this is already happening at the margin. For instance, purchases of Portuguese and Irish debt have been running well below the rate implied by the ECB’s capital key over recent months (see Chart 6). A more explicit shift from this weighting would buy more room for stimulus, but again be controversial on the Governing Council. Finally, the ECB could taper purchases, even if economic conditions do not improve. This would provide a blow to the central bank’s credibility and constitute a policy mistake if tightening financial conditions harmed the recovery. The ECB should not stop until it has finished the reflation job.
James McCann, Senior Global Economist
The document is intended for institutional investors and investment professionals only and should not be distributed to or relied upon by retail clients.
All information, opinions and estimates in this document are those of Standard Life Investments, and constitute our best judgement as of the date indicated and may be superseded by subsequent market events or other reasons.
The views and conclusions expressed in this communication are for general interest only and should not be taken as investment advice or as an invitation to purchase or sell any specific security.
Any data contained herein which is attributed to a third party ("Third Party Data") is the property of (a) third party supplier(s) (the "Owner") and is licensed for use by Standard Life**. Third Party Data may not be copied or distributed. Third Party Data is provided "as is" and is not warranted to be accurate, complete or timely. To the extent permitted by applicable law, none of the Owner, Standard Life** or any other third party (including any third party involved in providing and/or compiling Third Party Data) shall have any liability for Third Party Data or for any use made of Third Party Data. Past performance is no guarantee of future results. Neither the Owner nor any other third party sponsors, endorses or promotes the fund or product to which Third Party Data relates.
**Standard Life means the relevant member of the Standard Life group, being Standard Life plc together with its subsidiaries, subsidiary undertakings and associated companies (whether direct or indirect) from time to time.